Sacha, T., & Krawczyk, K. Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies. Elsevier.
Chicago Style (17th ed.) CitationSacha, Tomasz, and Katarzyna Krawczyk. Ponatinib in the Treatment of Patients with Chronic Myeloid Leukemia and Increased Cardiovascular Risk: A Review of Management Strategies. Elsevier.
MLA (9th ed.) CitationSacha, Tomasz, and Katarzyna Krawczyk. Ponatinib in the Treatment of Patients with Chronic Myeloid Leukemia and Increased Cardiovascular Risk: A Review of Management Strategies. Elsevier.
Warning: These citations may not always be 100% accurate.